Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.186 EUR | -31.11% | -19.13% | -.--% |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 20.87M 19.4M 1.64B |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.82% |
Latest transcript on iBio, Inc.
1 week | -19.13% | ||
1 month | -30.08% | ||
3 months | -35.86% | ||
6 months | -73.62% |
Managers | Title | Age | Since |
---|---|---|---|
Martin Brenner
CEO | Chief Executive Officer | 54 | 17/01/21 |
Felipe Duran
DFI | Director of Finance/CFO | 45 | 31/03/21 |
Phan Dillon
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chip Clark
CHM | Chairman | 56 | 22/08/21 |
Linda Armstrong
BRD | Director/Board Member | 61 | 13/10/20 |
Gary Sender
BRD | Director/Board Member | 62 | 13/10/20 |
1st Jan change | Capi. | |
---|---|---|
+47.47% | 765B | |
-6.24% | 354B | |
+20.40% | 331B | |
+9.58% | 299B | |
+18.87% | 248B | |
-1.96% | 219B | |
+11.11% | 216B | |
+5.18% | 164B | |
-2.21% | 162B |
- Stock Market
- Equities
- IBIO Stock
- 0JV0 Stock